Skip to main content

Closed

GPCR: Structure Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-14.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio26.16×

Structure Therapeutics Inc.

GPCRNASDAQ Global Market·USD·Closed

Structure Therapeutics Inc.

GPCRNASDAQ·USD·Closed

$48.04

−2.89%

$48.04

−$1.43 (2.89%)

52W Range

41thpctl

Volume

0.52×avg

Mkt Cap

2.77BUSD

P/E

-18.7TTM

Div Yield

–ann

52W Range

41thpctl

Volume

0.52×avg

Market Cap

2.77BUSD

P/E Ratio

-18.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings